Anesthesiology and Pain Medicine

Published by: Kowsar

The Efficacy of Systemic Lidocaine in the Management of Chronic Pain: A Literature Review

Fardin Yousefshahi 1 , 2 , Oana Predescu 3 and Juan Francisco Asenjo 4 , *
Authors Information
1 Department of Anesthesiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2 Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
3 Assistant Professor, Department of Anesthesia, McGill University Health Centre, Montreal, QC, Canada
4 Professor, Department of Anesthesia, McGill University Health Centre, Montreal, QC, Canada
Article information
  • Anesthesiology and Pain Medicine: June 2017, 7 (3); e44732
  • Published Online: April 22, 2017
  • Article Type: Review Article
  • Received: December 13, 2016
  • Revised: February 5, 2017
  • Accepted: March 11, 2017
  • DOI: 10.5812/aapm.44732

To Cite: Yousefshahi F, Predescu O, Francisco Asenjo J. The Efficacy of Systemic Lidocaine in the Management of Chronic Pain: A Literature Review, Anesth Pain Med. 2017 ; 7(3):e44732. doi: 10.5812/aapm.44732.

Abstract
Copyright © 2017, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Summary and Conclusion
4. Future Studies
Acknowledgements
Footnotes
References
  • 1. Gilron I, Jensen MP. Clinical trial methodology of pain treatment studies: selection and measurement of self-report primary outcomes for efficacy. Reg Anesth Pain Med. 2011; 36(4): 374-81[DOI][PubMed]
  • 2. Voscopoulos C, Lema M. When does acute pain become chronic? Br J Anaesth. 2010; 105 Suppl 1-85[DOI][PubMed]
  • 3. Mifflin KA, Kerr BJ. The transition from acute to chronic pain: understanding how different biological systems interact. Can J Anaesth. 2014; 61(2): 112-22[DOI][PubMed]
  • 4. Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol. 2010; 229(1-2): 26-50[DOI][PubMed]
  • 5. Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012; 11(7): 629-42[DOI][PubMed]
  • 6. Guillot X, Semerano L, Decker P, Falgarone G, Boissier MC. Pain and immunity. Joint Bone Spine. 2012; 79(3): 228-36[DOI][PubMed]
  • 7. Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2012; 12(4): 304-14[PubMed]
  • 8. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. Importance of glial activation in neuropathic pain. Eur J Pharmacol. 2013; 716(1-3): 106-19[DOI][PubMed]
  • 9. Golzari SE, Soleimanpour H, Mahmoodpoor A, Safari S, Ala A. Lidocaine and pain management in the emergency department: a review article. Anesth Pain Med. 2014; 4(1): 15444[DOI][PubMed]
  • 10. Yousefshahi F, Predescu O, Colizza M, Asenjo JF. Postthoracotomy Ipsilateral Shoulder Pain: A Literature Review on Characteristics and Treatment. Pain Res Manag. 2016; 2016: 3652726[DOI][PubMed]
  • 11. Hachenberg T. [Perioperative management with short-acting intravenous anesthetics]. Anaesthesiol Reanim. 2000; 25(6): 144-50[PubMed]
  • 12. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. EMLA reduces acute and chronic pain after breast surgery for cancer. Reg Anesth Pain Med. 2000; 25(4): 350-5[DOI][PubMed]
  • 13. Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 2000; 93(3): 858-75[PubMed]
  • 14. Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009; 109(5): 1464-9[DOI][PubMed]
  • 15. Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain. 2000; 87(1): 7-17[PubMed]
  • 16. Iwane T, Maruyama M, Matsuki M, Ito Y, Shimoji K. Management of intractable pain in adiposis dolorosa with intravenous administration of lidocaine. Anesth Analg. 1976; 55(2): 257-9[PubMed]
  • 17. Petersen P, Kastrup J, Zeeberg I, Boysen G. Chronic pain treatment with intravenous lidocaine. Neurol Res. 1986; 8(3): 189-90[PubMed]
  • 18. Sjogren P, Banning AM, Hebsgaard K, Petersen P, Gefke K. [Intravenous lidocaine in the treatment of chronic pain caused by bone metastases]. Ugeskr Laeger. 1989; 151(34): 2144-6[PubMed]
  • 19. van der Wal SE, van den Heuvel SA, Radema SA, van Berkum BF, Vaneker M, Steegers MA, et al. The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain. Eur J Pain. 2016; 20(5): 655-74[DOI][PubMed]
  • 20. Cahana A, Carota A, Montadon ML, Annoni JM. The long-term effect of repeated intravenous lidocaine on central pain and possible correlation in positron emission tomography measurements. Anesth Analg. 2004; 98(6): 1581-4[PubMed]
  • 21. Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs. 2004; 64(9): 937-47[PubMed]
  • 22. Geha PY, Baliki MN, Chialvo DR, Harden RN, Paice JA, Apkarian AV. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain. 2007; 128(1-2): 88-100[DOI][PubMed]
  • 23. Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain. 2000; 16(3): 205-8[PubMed]
  • 24. Fishbain DA, Lewis JE, Cole B, Cutler B, Rosomoff HL, Rosomoff RS. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response. Pain Med. 2006; 7(2): 135-42[DOI][PubMed]
  • 25. Hans G, Joukes E, Verhulst J, Vercauteren M. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases. Curr Med Res Opin. 2009; 25(11): 2737-43[DOI][PubMed]
  • 26. Wilhelm IR, Tzabazis A, Likar R, Sittl R, Griessinger N. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. Eur J Anaesthesiol. 2010; 27(2): 169-73[DOI][PubMed]
  • 27. Dirks J, Fabricius P, Petersen KL, Rowbotham MC, Dahl JB. The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Anesth Analg. 2000; 91(4): 967-72[PubMed]
  • 28. Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology. 2004; 62(2): 218-25[PubMed]
  • 29. Tremont-Lukats IW, Hutson PR, Backonja MM. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain. 2006; 22(3): 266-71[DOI][PubMed]
  • 30. Carroll IR, Younger JW, Mackey SC. Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain. Pain Med. 2010; 11(4): 617-21[DOI][PubMed]
  • 31. Galer BS, Gammaitoni AR, Oleka N, Jensen MP, Argoff CE. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin. 2004; 20 Suppl 2-12[DOI][PubMed]
  • 32. Hashmi JA, Baliki MN, Huang L, Parks EL, Chanda ML, Schnitzer T, et al. Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study. Mol Pain. 2012; 8: 29[DOI][PubMed]
  • 33. Galer BS, Sheldon E, Patel N, Codding C, Burch F, Gammaitoni AR. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opin. 2004; 20(9): 1455-8[DOI][PubMed]
  • 34. Gammaitoni AR, Galer BS, Onawola R, Jensen MP, Argoff CE. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin. 2004; 20 Suppl 2-9[DOI][PubMed]
  • 35. White WT, Patel N, Drass M, Nalamachu S. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med. 2003; 4(4): 321-30[PubMed]
  • 36. Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin. 2004; 20 Suppl 2-8[DOI][PubMed]
  • 37. Bafuma PJ, Nandi A, Weisberg M. Opiate refractory pain from an intestinal obstruction responsive to an intravenous lidocaine infusion. Am J Emerg Med. 2015; 33(10): 1544 e3-4[DOI][PubMed]
  • 38. Mooney JJ, Pagel PS, Kundu A. Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: a preliminary report. Pain Med. 2014; 15(5): 820-5[DOI][PubMed]
  • 39. Grigoras A, Lee P, Sattar F, Shorten G. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain. 2012; 28(7): 567-72[DOI][PubMed]
  • 40. Terkawi AS, Sharma S, Durieux ME, Thammishetti S, Brenin D, Tiouririne M. Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: a double-blind, placebo-controlled randomized trial. Pain Physician. 2015; 18(2)-46[PubMed]
  • 41. Chang YC, Liu CL, Liu TP, Yang PS, Chen MJ, Cheng SP. Effect of perioperative intravenous lidocaine infusion on acute and chronic pain after breast surgery: A meta-analysis of randomized controlled trials. . Official J World Institute Pain. 2016;
  • 42. Farag E, Ghobrial M, Sessler DI, Dalton JE, Liu J, Lee JH, et al. Effect of perioperative intravenous lidocaine administration on pain, opioid consumption, and quality of life after complex spine surgery. Anesthesiology. 2013; 119(4): 932-40[DOI][PubMed]
  • 43. Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, et al. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004; 98(4): 1050-5[PubMed]
  • 44. Kuo CP, Jao SW, Chen KM, Wong CS, Yeh CC, Sheen MJ, et al. Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth. 2006; 97(5): 640-6[DOI][PubMed]
  • 45. Swenson BR, Gottschalk A, Wells LT, Rowlingson JC, Thompson PW, Barclay M, et al. Intravenous lidocaine is as effective as epidural bupivacaine in reducing ileus duration, hospital stay, and pain after open colon resection: a randomized clinical trial. Reg Anesth Pain Med. 2010; 35(4): 370-6[DOI][PubMed]
  • 46. Kim TH, Kang H, Hong JH, Park JS, Baek CW, Kim JY, et al. Intraperitoneal and intravenous lidocaine for effective pain relief after laparoscopic appendectomy: a prospective, randomized, double-blind, placebo-controlled study. Surg Endosc. 2011; 25(10): 3183-90[DOI][PubMed]
  • 47. Tikuisis R, Miliauskas P, Samalavicius NE, Zurauskas A, Samalavicius R, Zabulis V. Intravenous lidocaine for post-operative pain relief after hand-assisted laparoscopic colon surgery: a randomized, placebo-controlled clinical trial. Tech Coloproctol. 2014; 18(4): 373-80[DOI][PubMed]
  • 48. Yang SY, Kang H, Choi GJ, Shin HY, Baek CW, Jung YH, et al. Efficacy of intraperitoneal and intravenous lidocaine on pain relief after laparoscopic cholecystectomy. J Int Med Res. 2014; 42(2): 307-19[DOI][PubMed]
  • 49. Alebouyeh MR, Imani F, Rahimzadeh P, Entezary SR, Faiz SH, Soraya P. Analgesic effects of adding lidocaine to morphine pumps after orthopedic surgeries. J Res Med Sci. 2014; 19(2): 122-7[PubMed]
  • 50. Kranke P, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015; (7)[DOI][PubMed]
  • 51. Hemati K, Zaman B, Hassani V, Imani F, Dariaie P. Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain. Anesth Pain Med. 2015; 5(1): 22900[DOI][PubMed]
  • 52. Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain Symptom Manage. 2009; 37(1): 85-93[DOI][PubMed]
  • 53. Salas S, Auquier P, Duffaud F, Garnier SR, Deschamps M, Honore S, et al. Efficacy of lidocaine in patients receiving palliative care with opioid-refractory cancer pain with a neuropathic component: study protocol for a randomized controlled study. Trials. 2014; 15: 318[DOI][PubMed]
  • 54. Vosoughian M, Dabbagh A, Rajaei S, Maftuh H. The duration of spinal anesthesia with 5% lidocaine in chronic opium abusers compared with nonabusers. Anesth Analg. 2007; 105(2): 531-3[DOI][PubMed]
  • 55. Dabbagh A, Moghadam SF, Rajaei S, Mansouri Z, Manaheji HS. Can repeated exposure to morphine change the spinal analgesic effects of lidocaine in rats? J Res Med Sci. 2011; 16(10): 1361-5
  • 56. Imani F, Hemati K, Rahimzadeh P, Kazemi MR, Hejazian K. Effectiveness of Stellate Ganglion Block Under Fuoroscopy or Ultrasound Guidance in Upper Extremity CRPS. J Clin Diagn Res. 2016; 10(1)-12[DOI][PubMed]
  • 57. Oaklander AL, Horowitz SH. The complex regional pain syndrome. Handb Clin Neurol. 2015; 131: 481-503[DOI][PubMed]
  • 58. Suresh S, Wheeler M, Patel A. Case series: IV regional anesthesia with ketorolac and lidocaine: is it effective for the management of complex regional pain syndrome 1 in children and adolescents? Anesth Analg. 2003; 96(3): 694-5[PubMed]
  • 59. Toda K, Muneshige H, Asou T. Intravenous regional block with lidocaine for treatment of complex regional pain syndrome. Clin J Pain. 2006; 22(2): 222-4[PubMed]
  • 60. Rickard JP, Kish T. Systemic Intravenous Lidocaine for the Treatment of Complex Regional Pain Syndrome: A Case Report and Literature Review. Am J Ther. 2016; 23(5)-9[DOI][PubMed]
  • 61. Paraskevas KI, Michaloglou AA, Briana DD, Samara M. Treatment of complex regional pain syndrome type I of the hand with a series of intravenous regional sympathetic blocks with guanethidine and lidocaine. Clin Rheumatol. 2006; 25(5): 687-93[DOI][PubMed]
  • 62. Eckmann MS, Ramamurthy S, Griffin JG. Intravenous regional ketorolac and lidocaine in the treatment of complex regional pain syndrome of the lower extremity: a randomized, double-blinded, crossover study. Clin J Pain. 2011; 27(3): 203-6[DOI][PubMed]
  • 63. Varitimidis SE, Papatheodorou LK, Dailiana ZH, Poultsides L, Malizos KN. Complex regional pain syndrome type I as a consequence of trauma or surgery to upper extremity: management with intravenous regional anaesthesia, using lidocaine and methyloprednisolone. J Hand Surg Eur Vol. 2011; 36(9): 771-7[DOI][PubMed]
  • 64. Taskaynatan MA, Ozgul A, Tan AK, Dincer K, Kalyon TA. Bier block with methylprednisolone and lidocaine in CRPS type I: a randomized, double-blinded, placebo-controlled study. Reg Anesth Pain Med. 2004; 29(5): 408-12[PubMed]
  • 65. Linchitz RM, Raheb JC. Subcutaneous infusion of lidocaine provides effective pain relief for CRPS patients. Clin J Pain. 1999; 15(1): 67-72[PubMed]
  • 66. Wallace MS, Ridgeway BM, Leung AY, Gerayli A, Yaksh TL. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology. 2000; 92(1): 75-83[PubMed]
  • 67. Schwartzman RJ, Patel M, Grothusen JR, Alexander GM. Efficacy of 5-day continuous lidocaine infusion for the treatment of refractory complex regional pain syndrome. Pain Med. 2009; 10(2): 401-12[DOI][PubMed]
  • 68. Frost SG. Treatment of complex regional pain syndrome type 1 in a pediatric patient using the lidocaine patch 5%: a case report. Curr Ther Res Clin Exp. 2003; 64(8): 626-9[DOI][PubMed]
  • 69. Vorobeychik Y, Giampetro DM. Topical lidocaine and epidural bupivacaine/hydromorphone in the treatment of complex regional pain syndrome type 2. Pain Physician. 2007; 10(3): 513-4[PubMed]
  • 70. Hanlan AK, Mah-Jones D, Mills PB. Early adjunct treatment with topical lidocaine results in improved pain and function in a patient with complex regional pain syndrome. Pain Physician. 2014; 17(5)-35[PubMed]
  • 71. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg. 1996; 82(1): 91-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments